Company intelligence / Profile preview

BioWink

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

BioWink developed the Clue app, which tracks and predicts menstrual cycles using user-inputted data such as mood, body temperature, sexual activity, pain level, PMS symptoms, exercise habits, and sleep. The app has been recognized for its accuracy in peer-reviewed journals and is used by millions worldwide. It also collaborates with leading academic institutions to advance research in female reproductive health.

Therapeutic areas: Women's Health
Modalities: Non-pharmacological therapy (digital/mobile health application)
Industry: Digital Health Medical Devices

Partnerships

Academic partnerships with Kinsey Institute, Stanford University, Columbia University, University of Oxford for research collaborations on women’s reproductive and sexual health

Beyond the preview

Go deeper on BioWink.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioWink.

Explore the full profile